SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-033451
Filing Date
2020-02-13
Accepted
2020-02-12 17:42:03
Documents
2
Group Members
NEW LEAF BPO ASSOCIATES I, L.P.NEW LEAF VENTURE ASSOCIATES IV, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.NEW LEAF VENTURE MANAGEMENT IV, L.L.CNEW LEAF VENTURES IV, L.P.RONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d886383dsc13ga.htm SC 13G/A 143735
2 EX-99.1 d886383dex991.htm EX-99.1 15230
  Complete submission text file 0001193125-20-033451.txt   161049
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89009 | Film No.: 20605758
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Biopharma Opportunities I, L.P. (Filed by) CIK: 0001625696 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A